📝 TCM Ltd — results explained
Quarter ended June 2026 (Q1 FY27)
TCM Ltd reported revenue of ₹4 crore for the quarter ended June 2026 (Q1 FY27), up 31.8% from ₹3 crore in the same quarter last year, and up 1.3% sequentially over the March 2026 quarter.
The company reported a net loss of ₹1 crore, against a net loss of ₹1 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-1.63.
Operating profit stood at ₹-1 crore — an operating margin (OPM) of -18.6%, compared with -40.7% in the year-ago quarter.
Full year and trailing twelve months
For the full year FY26, TCM Ltd posted revenue of ₹17 crore, a decline of 30.3% over FY25, with a net loss of ₹4 crore.
On a trailing-twelve-month (TTM) basis, revenue stands at ₹18 crore with a net loss of ₹3 crore.
Valuation snapshot
At the current price of ₹47.17, 524156 has a market capitalisation of ₹39 crore.
Within the Commodity Chemicals industry, it is the 25th-largest of the 50 companies we track by market value.
Shareholding pattern
As of Jun 2026, promoters held 49.51%, domestic institutional investors (DIIs) 7.44%, public shareholders 43.05% of TCM Ltd.